explore -WSS

explore

author：fashion 2025-10-01 18:08:12 - browse：13243

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Medicare bonuses could stop drug shortages under Senate plan

hotspot

WSS

TikTok, Instagram influencers need more rules for drug ads

Change Healthcare: What is it, why does its cyberattack matter?

Stem cell biologist probes earliest stages of human development

Future doctors need a strong humanities education

Printout prescription drug information shouldn’t go digital

Families look for replacement for GSK asthma drug Flovent

entertainment

explore

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Maisha Meds is a PBM, but don't call it that

In age of alternative facts, a scholarly course on calling out crap

Lack of health data on LGBTQ+ people has serious consequences

New air purifier tech could be key to improving indoor air quality

Head of FDA's diagnostics center, who led through Covid, retires

As demand for Covid shots wanes, Moderna seeks its next success

Inaction leaves children at risk from dangerous chemotherapy drug

Anesthesiologist group: stop taking Ozempic before surgery

Future doctors need a strong humanities education

leisure time

The public health thinking behind the CDC’s new Covid guidance

Pregnant women don't need prenatal multivitamins, study concludes

For AI in health care standards, federal regulators join with industry group

A pediatrician calls for Congress to pass the child tax credit deal

Pumping milk in bathrooms at health conferences is common

Mass General, Mayo Clinic look to monetize custom

Wikipedia

hotspot

leisure time

Wikipedia